US Broker Ratings

AdaptHealth Corp. (AHCO) Stock Analysis: A Promising 26% Upside in the Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO), a crucial player in the healthcare sector, specializes in the distribution of home medical equipment and supplies across the United States. With a robust portfolio that..

SS Innovations International (SSII) Investor Outlook: Exploring the 192.5% Revenue Growth in India’s Booming Medical Device Sector

SS Innovations International Inc. (SSII), a key player in the healthcare sector, is making waves in the medical device industry with its rapid revenue growth and innovative surgical robotics technology...

Vera Therapeutics (VERA) Stock Analysis: Biotech with 61.59% Potential Upside

Vera Therapeutics, Inc. (NASDAQ: VERA) is capturing the attention of investors with its promising potential upside of 61.59%. This clinical-stage biotechnology company is making waves in the healthcare sector with..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a Potential 108% Upside in Biotech Innovation

Celldex Therapeutics, Inc. (NASDAQ: CLDX) has captured the attention of investors with its promising biopharmaceutical developments and a notable potential upside of 108.02%. As a key player in the biotechnology..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring its 36.88% Upside Potential

Astrana Health Inc. (NASDAQ: ASTH), a healthcare management company based in Alhambra, California, is making waves in the medical care facilities industry. With a market capitalization of $1.35 billion, Astrana..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Exploring a 22% Potential Upside in Biotech

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a dynamic player in the biotechnology sector, offers investors a compelling narrative with its strong revenue growth and promising pipeline of dermatological treatments. Headquartered in..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Riding the Biotech Wave with a 3.28% Potential Upside

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a key player in the biotechnology sector, continues to capture investor interest with its innovative approach to treating rare diseases. Headquartered in Princeton, New Jersey,..

Ascentage Pharma Group (AAPG) Stock Analysis: Unpacking Its 69% Potential Upside

Investors keen on the biotechnology sector might find a compelling opportunity in Ascentage Pharma Group International (AAPG), particularly given its notable potential upside of 69%. This China-based clinical-stage biotechnology company,..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: A Biotech Powerhouse with 134% Upside Potential

In the ever-evolving landscape of biotechnology, Dyne Therapeutics, Inc. (NASDAQ: DYN) is emerging as a beacon of innovation and potential. As a clinical-stage company focused on developing therapeutics for neuromuscular..

Kestra Medical Technologies (KMTS): A Promising Healthcare Innovator with 26.91% Potential Upside

For investors seeking opportunities in the dynamic healthcare sector, Kestra Medical Technologies, Ltd. (KMTS) offers a compelling proposition with its innovative approach to cardiovascular care. Based in Kirkland, Washington, and..

LivaNova PLC (LIVN) Stock Analysis: Capitalizing on a 17.53% Potential Upside in the Healthcare Sector

LivaNova PLC (NASDAQ: LIVN), a key player in the healthcare sector, is drawing investor attention with a promising 17.53% potential upside, according to the latest analyst ratings. As a medical..

Adaptive Biotechnologies Corporation (ADPT) Stock Analysis: Unpacking the 14% Potential Upside

Adaptive Biotechnologies Corporation (ADPT), a pioneering entity in the biotechnology sector, stands at the forefront of immune medicine innovations. With its headquarters nestled in Seattle, Washington, the company is a..

Evotec SE (EVO): Analyst Consensus Foresees 54% Upside Potential Amidst Strategic Partnerships

Evotec SE (EVO), a prominent player in the healthcare sector under the umbrella of drug manufacturers specializing in both specialty and generic medications, continues to attract attention from investors with..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Biotech Innovator Poised for 14% Upside Potential

PTC Therapeutics, Inc. (NASDAQ: PTCT), a prominent player in the biotechnology sector, is gaining attention from investors due to its promising growth prospects and strategic position in the healthcare market...

PROCEPT BioRobotics (PRCT) Stock Analysis: Navigating a 66.98% Potential Upside in the Medical Device Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a pioneer in the healthcare sector, is making waves in the medical device industry with its innovative surgical robotics solutions. Headquartered in San Jose, California,..

GRAIL, Inc. (GRAL) Investor Outlook: Assessing the 8.58% Potential Upside in Healthcare Diagnostics

GRAIL, Inc. (GRAL), a standout player in the healthcare diagnostics and research sector, is capturing investor attention with a promising 8.58% potential upside. As a commercial-stage company focused on multi-cancer..

Liquidia Corporation (LQDA) Stock Analysis: Exploring the 20% Upside Potential Amidst Groundbreaking Revenue Growth

Liquidia Corporation (NASDAQ: LQDA), a promising player in the biotechnology sector, has captured the attention of investors with its impressive revenue growth and potential upside. Based in Morrisville, North Carolina,..

National HealthCare Corporation (NHC) Stock Analysis: Steady Revenue Growth Amidst Unrated Territory

National HealthCare Corporation (NYSE: NHC) operates within the healthcare sector, specializing in medical care facilities. With a market capitalization of $2.13 billion, the company is a significant player in the..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 26.13% Potential Upside Amidst Challenging Metrics

Investors are taking a keen look at Neogen Corporation (NYSE: NEOG), a prominent player in the diagnostics and research industry with a focus on food and animal safety. With a..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring a 76.77% Potential Upside in the Biotech Sector

Investors with an eye on the healthcare sector may find Centessa Pharmaceuticals plc (NASDAQ: CNTA) an intriguing opportunity. This UK-based biotechnology company, with a market capitalization of $3.28 billion, has..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds